Dietary Supplements for Weight Loss: Evidence-Graded Reference List

Dietary supplements marketed for weight loss number in the thousands in the UK. The regulatory landscape allows food supplements to be sold without pre-market efficacy proof. Below is a reference guide to the most commonly encountered weight loss supplement ingredients, with evidence assessment for each.

Evidence Grade Key

• A — Strong: Multiple independent RCTs; Cochrane review; regulatory approval or authorised health claim
• B — Moderate: Multiple smaller RCTs or meta-analyses with meaningful effect; no EFSA-authorised claim
• C — Limited: Small studies, inconsistent results, or insufficient human data
• D — No credible evidence: EFSA claim rejected; no credible RCT evidence in humans; or evidence of harm

Grade A Ingredients (Strong Evidence)

Glucomannan (Konjac Fibre)

Mechanism: Soluble fibre; forms viscous gel in stomach slowing gastric emptying; increases GLP-1, PYY (satiety hormones); reduces postprandial glucose spike.

Evidence: EFSA-authorised health claim: "Glucomannan in the context of an energy-restricted diet contributes to weight loss." Multiple RCTs; 2005 systematic review found −0.79 to −1.7kg additional weight loss versus placebo.

Effective dose: 3g/day in 3 divided doses before meals with ≥250ml water.

Realistic effect: Approximately 0.8–1.5kg additional weight loss over 12 weeks versus calorie restriction alone.

Safety: Generally well-tolerated; choking risk if swallowed without adequate water; GI discomfort at high doses.

Grade B Ingredients (Moderate Evidence)

Caffeine

Mechanism: Adenosine receptor antagonist; increases sympathetic nervous system activity; increases BMR 3–11%; enhances fat oxidation during exercise.

Evidence: Multiple RCTs demonstrate thermogenic effect; EFSA did not authorise weight loss claim finding insufficient long-term evidence. Well-established thermogenic mechanism.

Effective dose: 100–200mg per dose; tolerance develops with habitual use.

Realistic effect: Approximately 50–100 kcal/day additional thermogenesis; tolerance limits sustained effect.

Safety: Safe at <400mg/day; avoid in hypertension, arrhythmia, pregnancy; interacts with adenosine-pathway drugs.

EGCG (Green Tea Catechins)

Mechanism: Inhibits COMT enzyme; slows noradrenaline breakdown; synergistic with caffeine for thermogenesis; modest fat oxidation enhancement.

Evidence: Cochrane review (2012, 11 RCTs) found −0.95kg additional weight loss versus control. EFSA did not authorise weight loss claim finding insufficient evidence.

Effective dose: 270–800mg EGCG/day; effect greater in caffeine non-tolerant individuals.

Realistic effect: Approximately 80–100 kcal/day additional thermogenesis; −1kg over 12 weeks.

Safety: Hepatotoxicity risk at >800mg EGCG/day from supplements (not from brewed tea). EFSA identified this safety concern.

Protein Supplementation (Whey, Plant Protein)

Mechanism: Increases TEF (thermic effect of food); highest thermic effect macronutrient; increases satiety hormones (GLP-1, PYY, CCK); preserves lean mass during calorie restriction.

Evidence: Multiple RCTs demonstrate protein's satiety and lean mass preservation effects. EFSA authorised health claims for protein and satiety (though not specific weight loss claims).

Effective dose: 1.6–2.2g total protein/kg/day; 25–40g per meal for leucine threshold.

Realistic effect: High-protein diet reduces spontaneous energy intake by approximately 440 kcal/day in RCTs; reduces lean mass loss during deficit.

Safety: Generally safe; concern about renal load is not evidenced at typical supplement doses in healthy adults.

Grade C Ingredients (Limited Evidence)

Garcinia Cambogia / HCA

Mechanism: Hydroxycitric acid (HCA) inhibits citrate lyase (fatty acid synthesis enzyme) in vitro.

Evidence: 2011 meta-analysis (Onakpoya et al., 11 RCTs) found −0.88kg additional weight loss; several null results in high-quality trials. EFSA rejected health claim.

Safety: Generally tolerated; hepatotoxicity cases reported at high doses; serotonin-related caution.

CLA (Conjugated Linoleic Acid)

Mechanism: Alters fat cell metabolism; activates PPARα; reduces fat storage in some animal models.

Evidence: Meta-analysis (2012, 18 RCTs) found −1.33kg fat mass reduction versus placebo over 12+ weeks. Concerns about pro-inflammatory and possible insulin resistance effects at high doses. EFSA rejected fat loss claims.

Safety: Mild increase in inflammatory markers at supplemental doses; possible insulin resistance at high doses.

Phaseolamin (White Kidney Bean Extract)

Mechanism: Inhibits alpha-amylase (starch-digesting enzyme); reduces carbohydrate absorption from meals.

Evidence: Several small RCTs show modest weight loss; inconsistent results. EFSA rejected health claim.

Realistic effect: If active, reduces calorie absorption from starchy meals — not fat-specific.

Safety: Digestive discomfort common; avoid if on diabetes medication.

Berberine

Mechanism: Activates AMPK; reduces hepatic glucose production; mechanism similar to metformin.

Evidence: Multiple RCTs show HbA1c and blood glucose reduction comparable to low-dose metformin. Weight loss RCT evidence is less consistent and smaller scale. Not primarily studied as weight loss supplement — studied for metabolic syndrome and type 2 diabetes management.

Safety: Significant drug interaction risk — inhibits CYP3A4; interacts with metformin, anticoagulants, statins. Not appropriate to self-supplement if on prescription medication without GP consultation.

L-Carnitine

Mechanism: Transports long-chain fatty acids into mitochondria for oxidation.

Evidence: A 2020 meta-analysis found modest weight reduction (−1.33kg) and BMI reduction versus control. Effects primarily in overweight older adults; evidence in healthy young adults less convincing. EFSA rejected weight loss and fat oxidation claims.

Chromium Picolinate

Mechanism: Enhances insulin signalling; may reduce carbohydrate craving.

Evidence: Multiple small RCTs; meta-analysis findings inconsistent. A 2019 Cochrane review found insufficient evidence for weight loss. Modest but real reduction in hunger and cravings in some studies. EFSA rejected all chromium weight management claims.

Grade D Ingredients (No Credible Evidence or Evidence of Harm)

Raspberry Ketones

Evidence: No human RCT evidence. In vitro and rodent data only. Marketed heavily based on preclinical studies that have not been replicated in human trials. EFSA rejected claims.

Synephrine (Bitter Orange/Citrus aurantium)

Mechanism: Adrenergic amine; mechanism similar to ephedrine.

Evidence: Weak; cardiovascular adverse event risk documented. MHRA and FDA caution. Not recommended.

"Detox" and "Cleanse" Blends

Evidence: No credible mechanism or clinical evidence. "Detoxification" is performed by liver and kidneys continuously; no supplement enhances this. EFSA rejected all detox claims. Category D across all products.

High-Dose Antioxidant Supplements for Weight Loss

Evidence: No credible evidence for fat loss. CARET trial found high-dose beta-carotene increased lung cancer risk in smokers. Grade D for weight loss; Grade D for safety in specific populations.

Important Safety Notes for All Weight Loss Supplements

Pharmaceutical adulteration: MHRA has documented weight loss supplements containing sibutramine (withdrawn appetite suppressant), DNP (metabolic uncoupler with documented fatalities), phenolphthalein (carcinogen), and phenethylamines. This risk is highest for supplements purchased online from unknown brands.

Interactions: Weight loss supplements can interact with prescribed medications through cytochrome P450 enzyme inhibition or induction, direct pharmacological mechanisms, or effects on blood glucose (relevant for diabetes medication).

Pregnancy: No weight loss supplement is appropriate during pregnancy. Several ingredients (high-dose caffeine, synephrine, herbal extracts) have documented or possible teratogenic effects.

MHRA Yellow Card: Report suspected adverse events from any dietary supplement at yellowcard.mhra.gov.uk.

Disclaimer: This reference guide is for informational and educational purposes only. Before taking any weight loss supplement, consult your GP or pharmacist, particularly if you take prescription medication or have cardiovascular, hepatic, or endocrine conditions.